» Articles » PMID: 22013209

What Genetics Tells Us About the Causes and Mechanisms of Parkinson's Disease

Overview
Journal Physiol Rev
Specialty Physiology
Date 2011 Oct 21
PMID 22013209
Citations 270
Authors
Affiliations
Soon will be listed here.
Abstract

Parkinson's disease (PD) is a common motor disorder of mysterious etiology. It is due to the progressive degeneration of the dopaminergic neurons of the substantia nigra and is accompanied by the appearance of intraneuronal inclusions enriched in α-synuclein, the Lewy bodies. It is becoming increasingly clear that genetic factors contribute to its complex pathogenesis. Over the past decade, the genetic basis of rare PD forms with Mendelian inheritance, representing no more than 10% of the cases, has been investigated. More than 16 loci and 11 associated genes have been identified so far; genome-wide association studies have provided convincing evidence that polymorphic variants in these genes contribute to sporadic PD. The knowledge acquired of the functions of their protein products has revealed pathways of neurodegeneration that may be shared between inherited and sporadic PD. An impressive set of data in different model systems strongly suggest that mitochondrial dysfunction plays a central role in clinically similar, early-onset autosomal recessive PD forms caused by parkin and PINK1, and possibly DJ-1 gene mutations. In contrast, α-synuclein accumulation in Lewy bodies defines a spectrum of disorders ranging from typical late-onset PD to PD dementia and including sporadic and autosomal dominant PD forms due to mutations in SCNA and LRRK2. However, the pathological role of Lewy bodies remains uncertain, as they may or may not be present in PD forms with one and the same LRRK2 mutation. Impairment of autophagy-based protein/organelle degradation pathways is emerging as a possible unifying but still fragile pathogenic scenario in PD. Strengthening these discoveries and finding other convergence points by identifying new genes responsible for Mendelian forms of PD and exploring their functions and relationships are the main challenges of the next decade. It is also the way to follow to open new promising avenues of neuroprotective treatment for this devastating disorder.

Citing Articles

Neuroprotective role and mechanistic insights of DJ-1 dimerization in Parkinson's disease.

Lv L, Zhang H, Tan J, Wang C Cell Commun Signal. 2025; 23(1):129.

PMID: 40065349 PMC: 11892234. DOI: 10.1186/s12964-025-02136-9.


Updated MDSGene review on the clinical and genetic spectrum of LRRK2 variants in Parkinson´s disease.

Kruger C, Lim S, Buhrmann A, Fahrig F, Gabbert C, Bahr N NPJ Parkinsons Dis. 2025; 11(1):30.

PMID: 39962078 PMC: 11832785. DOI: 10.1038/s41531-025-00881-9.


Early Synapse-Specific Alterations of Photoreceptor Mitochondria in the EAE Mouse Model of Multiple Sclerosis.

Ibrahim D, Schwarz K, Suiwal S, Maragkou S, Schmitz F Cells. 2025; 14(3).

PMID: 39936997 PMC: 11816939. DOI: 10.3390/cells14030206.


Roles of endoplasmic reticulum stress and activating transcription factors in Alzheimer's disease and Parkinson's disease.

Cheng C, Cheng E, Ku H Tzu Chi Med J. 2025; 37(1):10-16.

PMID: 39850398 PMC: 11753521. DOI: 10.4103/tcmj.tcmj_51_24.


Biomarkers of Parkinson's Disease.

Sahai A, Saxena K Ann Neurosci. 2024; :09727531241301878.

PMID: 39712433 PMC: 11656457. DOI: 10.1177/09727531241301878.